VEGF-A 164 Variant (mouse, recombinant)

• Short Description:

  Catalog Number: B2017306 (5 µg)_x000D_ VEGF-A 164 Variant (mouse, recombinant) is a form of Vascular Endothelial Growth Factor A from mice, produced via recombinant DNA technology. It plays a key role in angiogenesis, forming new blood vessels. The "164" indicates the number of amino acids in this isoform. This protein is used in research to study angiogenesis and develop therapeutic strategies. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Description:

  VEGF-A 164 Variant (mouse, recombinant)_x000D_ Catalog number: B2017306_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 5 µg_x000D_ Molecular Weight or Concentration: 19.4 kDa_x000D_ Supplied as: Powder_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: ˆ’80°C_x000D_ Keywords: Vascular Endothelial Growth Factor A 164 variant_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, Chen B, Xu L, Liang Y, Jamieson AC, Zhang L, Spratt SK, Case CC, Wolffe A, Giordano FJ. Induction of angiogenesis in a mouse model using engineered transcription factors Nat Med. 2002 Dec;8(12):1427-32._x000D_ 2: Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, Lee M, Lee S, Lim BJ, Kim BS, Plotkin MD, Ha SK, Park HC. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury PLoS One. 2014 Feb 4;9(2):e87853._x000D_ 3: Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS. Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature Mol Cell Biol. 2000 Oct;20(19):7282-91._x000D_ 4: Li X, Gu F, Niu C, Wang Y, Liu Z, Li N, Pan B, He D, Kong J, Zhang S, Wang X, Yao Y, Zheng L. VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth J Transl Med. 2015 May 20;13:164._x000D_ 5: Turner RJ, Eikmans M, Bajema IM, Bruijn JA, Baelde HJ. Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease PLoS One. 2016 Sep 6;11(9):e0162166._x000D_ 6: Harris S, Craze M, Newton J, Fisher M, Shima DT, Tozer GM, Kanthou C. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale PLoS One. 2012;7(5):e35231._x000D_ 7: Keller-Baruch J, Forgetta V, Manousaki D, Zhou S, Richards JB. Genetically Decreased Circulating Vascular Endothelial Growth Factor and Osteoporosis Outcomes: A Mendelian Randomization Study J Bone Miner Res. 2020 Apr;35(4):649-656._x000D_ 8: Petersen W, Pufe T, Unterhauser F, Zantop T, Mentlein R, Weiler A. The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing Arch Orthop Trauma Surg. 2003 Nov;123(9):475-80._x000D_ 9: Kang WK, Lee MH, Kim YH, Kim MY, Kim JY. Enhanced secretion of biologically active, non-glycosylated VEGF from Saccharomyces cerevisiae J Biotechnol. 2013 Apr 15;164(4):441-8._x000D_ 10: Usui T, Ishida S, Yamashiro K, Kaji Y, Poulaki V, Moore J, Moore T, Amano S, Horikawa Y, Dartt D, Golding M, Shima DT, Adamis AP. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2 Invest Ophthalmol Vis Sci. 2004 Feb;45(2):368-74. _x000D_ _x000D_ Products Related to VEGF-A 164 Variant (mouse, recombinant) can be found at Proteins

• CAS Number:

  9000-83-3

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5